Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16871252.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Myostatin and the insulin-like growth factors (IGF-I and -II) play inhibitory and stimulatory roles, respectively, in the development and regulation of skeletal muscle mass. The findings of Sun et al. in this issue shed light on the potential regulation and actions of this yin-and-yang system in uremic sarcopenia and the salutary effects of exercise.
Medical subject headings
- Muscular Atrophy
- Somatomedins
- Transforming Growth Factor beta
- Uremia